Top brokers name 3 ASX shares to buy today

Top brokers have given buy rating to Afterpay Ltd (ASX:APT) and these ASX shares this week. Here's why they are bullish…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many of Australia's top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.

Three broker buy ratings that have caught my eye are summarised below. Here's why brokers think these ASX shares are in the buy zone:

Afterpay Ltd (ASX: APT)

According to a note out of Goldman Sachs, its analysts have retained their conviction buy rating and $42.90 price target on this payments company's shares. The broker has been looking through its expectations for Afterpay in the first half and appears confident another stellar result is coming. Goldman suspects that a strong end to the year means it could beat its customer additions and gross merchandise value estimates by around 10%. I agree with Goldman Sachs and would be a buyer of Afterpay's shares.

LiveTiles Ltd (ASX: LVT)

A note out of Citi reveals that its analysts have retained their buy rating but cut the price target on this intelligent workplace platform provider's shares to 63 cents. According to the note, Citi expects LiveTiles' performance to have improved greatly in the second quarter following a soft start to the new financial year. Whilst I think that LiveTiles has a lot of potential, I would suggest investors wait to see how it has performed in the second quarter before considering an investment.

Tyro Payments Ltd (ASX: TYR)

Analysts at Morgan Stanley have initiated coverage on this payments company with an overweight rating and $4.15 price target. According to the note, the broker likes Tyro Payments due to its exposure to a growing card payments market. And while it expects its operations to be loss-making in the near term, it appears positive on the Australian merchant acquirer's long term prospects. I like Tyro Payments but I would like to see how it performs in FY 2020 before looking at an investment.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended LIVETILES FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »